ID   HXC10_HUMAN             Reviewed;         342 AA.
AC   Q9NYD6; O15219; O15220; Q9BVD5;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   28-JUN-2023, entry version 185.
DE   RecName: Full=Homeobox protein Hox-C10;
DE   AltName: Full=Homeobox protein Hox-3I;
GN   Name=HOXC10; Synonyms=HOX3I;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10835276; DOI=10.1006/jmbi.2000.3782;
RA   de Stanchina E., Gabellini D., Norio P., Giacca M., Peverali F.A., Riva S.,
RA   Falaschi A., Biamonti G.;
RT   "Selection of homeotic proteins for binding to a human DNA replication
RT   origin.";
RL   J. Mol. Biol. 299:667-680(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 94-106 AND 258-297.
RX   PubMed=9357979; DOI=10.1016/s0014-5793(97)01118-6;
RA   Flagiello D., Gibaud A., Dutrillaux B., Poupon M.-F., Malfoy B.;
RT   "Distinct patterns of all-trans retinoic acid dependent expression of HOXB
RT   and HOXC homeogenes in human embryonal and small-cell lung carcinoma cell
RT   lines.";
RL   FEBS Lett. 415:263-267(1997).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-8 AND SER-189, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-254, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [8]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-254, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [9]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-106; LYS-195 AND LYS-254, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of a
CC       developmental regulatory system that provides cells with specific
CC       positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       Q9NYD6; Q9UK80: USP21; NbExp=3; IntAct=EBI-1188075, EBI-373242;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF255675; AAF67759.1; -; mRNA.
DR   EMBL; BC001293; AAH01293.1; -; mRNA.
DR   EMBL; X99684; CAA67999.1; -; mRNA.
DR   EMBL; X99685; CAA68000.1; -; mRNA.
DR   CCDS; CCDS8868.1; -.
DR   PIR; B60941; B60941.
DR   RefSeq; NP_059105.2; NM_017409.3.
DR   AlphaFoldDB; Q9NYD6; -.
DR   SMR; Q9NYD6; -.
DR   BioGRID; 109466; 21.
DR   IntAct; Q9NYD6; 9.
DR   STRING; 9606.ENSP00000307321; -.
DR   GlyCosmos; Q9NYD6; 1 site, 1 glycan.
DR   GlyGen; Q9NYD6; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; Q9NYD6; -.
DR   PhosphoSitePlus; Q9NYD6; -.
DR   BioMuta; HOXC10; -.
DR   jPOST; Q9NYD6; -.
DR   MassIVE; Q9NYD6; -.
DR   MaxQB; Q9NYD6; -.
DR   PaxDb; Q9NYD6; -.
DR   PeptideAtlas; Q9NYD6; -.
DR   ProteomicsDB; 83216; -.
DR   Antibodypedia; 15311; 497 antibodies from 34 providers.
DR   DNASU; 3226; -.
DR   Ensembl; ENST00000303460.5; ENSP00000307321.4; ENSG00000180818.5.
DR   GeneID; 3226; -.
DR   KEGG; hsa:3226; -.
DR   MANE-Select; ENST00000303460.5; ENSP00000307321.4; NM_017409.4; NP_059105.2.
DR   UCSC; uc001sen.4; human.
DR   AGR; HGNC:5122; -.
DR   CTD; 3226; -.
DR   DisGeNET; 3226; -.
DR   GeneCards; HOXC10; -.
DR   HGNC; HGNC:5122; HOXC10.
DR   HPA; ENSG00000180818; Tissue enriched (skeletal).
DR   MIM; 605560; gene.
DR   neXtProt; NX_Q9NYD6; -.
DR   OpenTargets; ENSG00000180818; -.
DR   PharmGKB; PA29397; -.
DR   VEuPathDB; HostDB:ENSG00000180818; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   GeneTree; ENSGT00940000160855; -.
DR   HOGENOM; CLU_057871_0_0_1; -.
DR   InParanoid; Q9NYD6; -.
DR   OMA; QGMYMQS; -.
DR   OrthoDB; 728401at2759; -.
DR   PhylomeDB; Q9NYD6; -.
DR   TreeFam; TF317819; -.
DR   PathwayCommons; Q9NYD6; -.
DR   SignaLink; Q9NYD6; -.
DR   SIGNOR; Q9NYD6; -.
DR   BioGRID-ORCS; 3226; 135 hits in 1170 CRISPR screens.
DR   GeneWiki; HOXC10; -.
DR   GenomeRNAi; 3226; -.
DR   Pharos; Q9NYD6; Tbio.
DR   PRO; PR:Q9NYD6; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9NYD6; protein.
DR   Bgee; ENSG00000180818; Expressed in gastrocnemius and 116 other tissues.
DR   ExpressionAtlas; Q9NYD6; baseline and differential.
DR   Genevisible; Q9NYD6; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; IMP:YuBioLab.
DR   GO; GO:0050905; P:neuromuscular process; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:ProtInc.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   GO; GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   Gene3D; 1.10.10.60; Homeodomain-like; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR046333; HXA10/ABDB-like.
DR   PANTHER; PTHR45874; HOMEOBOX PROTEIN ABDOMINAL-B; 1.
DR   PANTHER; PTHR45874:SF2; HOMEOBOX PROTEIN HOX-C10; 1.
DR   Pfam; PF00046; Homeodomain; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; Homeodomain-like; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Developmental protein; DNA-binding; Homeobox; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..342
FT                   /note="Homeobox protein Hox-C10"
FT                   /id="PRO_0000200190"
FT   DNA_BIND        268..327
FT                   /note="Homeobox"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          187..271
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        200..225
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        227..255
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         8
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         189
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   CROSSLNK        106
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        195
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        254
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:25772364, ECO:0007744|PubMed:28112733"
FT   CONFLICT        118
FT                   /note="K -> N (in Ref. 1; AAF67759)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        265
FT                   /note="A -> G (in Ref. 3; CAA68000)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        271
FT                   /note="Missing (in Ref. 3; CAA68000)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   342 AA;  38073 MW;  BD8127FD43C2A37B CRC64;
     MTCPRNVTPN SYAEPLAAPG GGERYSRSAG MYMQSGSDFN CGVMRGCGLA PSLSKRDEGS
     SPSLALNTYP SYLSQLDSWG DPKAAYRLEQ PVGRPLSSCS YPPSVKEENV CCMYSAEKRA
     KSGPEAALYS HPLPESCLGE HEVPVPSYYR ASPSYSALDK TPHCSGANDF EAPFEQRASL
     NPRAEHLESP QLGGKVSFPE TPKSDSQTPS PNEIKTEQSL AGPKGSPSES EKERAKAADS
     SPDTSDNEAK EEIKAENTTG NWLTAKSGRK KRCPYTKHQT LELEKEFLFN MYLTRERRLE
     ISKTINLTDR QVKIWFQNRR MKLKKMNREN RIRELTSNFN FT
//
